ANK-700

· Anokion SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANK-700, covering 2025-05-31 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis [Phase 1]